Results
1 -
10 of
42A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma, Journal of Neuro-Oncology Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas, Journal of Neuro-Oncology New targeted therapies in gastrointestinal cancers, Current Treatment Options in Oncology K-ras Inhibitors and Pancreatic Cancer, Pancreatic Cancer Treatment of Metastatic Head and Neck Cancer: Chemotherapy and Novel Agents, Head and Neck Cancer Early Clinical Experience with Farnesyl Protein Transferase Inhibitors, Farnesyltransferase Inhibitors in Cancer Therapy ras Oncogene Inhibitors, Cancer Chemoprevention Farnesyl Protein Transferase Inhibitors in Pancreatic Cancer, Pancreatic Disease Elongation factor 2 kinase, Springer Handbook of Enzymes Recent R&D Highlights, Pharmaceutical & Diagnostic Innovation